PMCPA Case
| Case number | AUTH/3322/3/20 |
| Company | Bayer |
| Complainant | A concerned UK health professional |
| Medicine | Xarelto (rivaroxaban) |
| Material | Two commissioned videos hosted on the ‘Guidelines in Practice’ website |
| Allegation | Disguised promotion |
| Clause(s) considered | Clause 12.1 |
| Decision | No breach |
| Complaint received | 10 March 2020 |
| Case completed | 17 June 2020 |
| Applicable Code year | 2019 |
| Appeal | No appeal |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.